Page last updated: 2024-10-21
ag-1549 and Diarrhea
ag-1549 has been researched along with Diarrhea in 1 studies
capravirine: a non-nucleoside reverse transcriptase inhibitor
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gewurz, BE | 1 |
| Jacobs, M | 1 |
| Proper, JA | 1 |
| Dahl, TA | 1 |
| Fujiwara, T | 1 |
| Dezube, BJ | 1 |
Trials
1 trial available for ag-1549 and Diarrhea
| Article | Year |
|---|---|
Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.
Topics: Administration, Oral; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Female; HIV Infections; HIV-1 | 2004 |